Three scientists from Keck Medicine of USC have won grants exceeding $4.3 million from the California Institute for Regenerative Medicine (CIRM) for research that includes creating a temporary liver for patients, finding novel ways to treat immune disorders and blood diseases, and developing new animal models for heart failure, diabetes and neurodegenerative diseases. The grants, …
Justin Ichida keeps his research patient-based. That’s why Ichida, Richard N. Merkin, M.D., Assistant Professor of Stem Cell Biology and Regenerative Medicine at the Keck School of Medicine of USC, and his startup company AcuraStem participated in the ALS Association Golden West Chapter Walk to Defeat ALS at Exposition Park in Los Angeles.
Approximately 50 million Americans suffer from autoimmune disease, according to the American Autoimmune Related Diseases Association. This includes the millions suffering from rheumatoid arthritis and lupus. Researchers at USC have developed novel small molecule drugs in regenerative and anti-inflammatory medicine that aim to provide relief and healing for patients with these diseases.
